Vectura data to be shared at ATS 2019
15th May 2019
Vectura is sharing new data at the ATS International Conference 2019 in Dallas, US.
We’re proud of our research and development, and five poster presentations will focus on our AKITA® JET smart nebuliser platform and VR647 development programme.
We will also take the opportunity to discuss the data and future projects with key opinion leaders who will be attending the congress.
ATS is one of the most important medical conferences in the respiratory calendar. Since 1905 it has grown to attract around 14,000 physicians and scientists from around the globe.
You can find details of our presentations below. On each day, the presenter will be available between 11am and 1pm to discuss the poster.
Poster 1: Sunday 19th May
Pharmacokinetics, safety and tolerability of single doses of budesonide delivered by AKITA® JET and conventional nebuliser in healthy adult volunteers and patients with asthma
Presented by Gary Burgess, VP Medical
A32 Asthma: Clinical studies II. Thematic posters: 9.15-4.15. Area E, Hall F (Level 2) KBHCCD
Poster 2: Wednesday 22nd May
Pharmacokinetics of budesonide suspension delivered by the VR647 inhalation system in paediatric patients with wheezing, reactive airway disease or mild asthma
Presented by Dr Craig LaForce, North
Carolina Clinical Research
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15-3.30. Area H, Hall F (Level 2) KBHCCD
Poster 3: Wednesday 22nd May
Pharmacokinetic modelling of budesonide delivery with the VR647 inhalation system, a novel paediatric inhalation device, for Phase 3 study dose selection
Presented by Bernhard Muellinger, VP Inhalation Technology
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15- 3.30. Area H, Hall F (Level 2). KBHCCD
Poster 4: Wednesday 22nd May
An open-label, non-drug study to evaluate the use of a mouthpiece with the VR647 inhalation system in patients aged less than five years
Presented by Professor Leonard Bacharier,
University School of Medicine
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15- 3.30. Area H, Hall F (Level 2) KBHCCD
Poster 5: Wednesday 22nd May
Patient satisfaction with the VR647 inhalation system: Data from two studies in paediatric patients
Presented by Anna Ribera, Director – Medical Affairs
D53 Paediatric Asthma Clinical studies. Thematic posters: 9.15- 3.30. Area H Hall F (Level 2). KBHCCD